References
- Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17:20-33. https://doi.org/10.1016/j.cmet.2012.11.012
- Nicholls SJ, Tuzcu EM, Kalidindi S, Wolski K, Moon KW, Sipahi I, Schoenhagen P, Nissen SE. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J Am Coll Cardiol. 2008;52:255-262. https://doi.org/10.1016/j.jacc.2008.03.051
- Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9:434-449. https://doi.org/10.1111/1753-0407.12521
- Yuan T, Yang T, Chen H, Fu D, Hu Y, Wang J, Yuan Q, Yu H, Xu W, Xie X. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. Redox Biol. 2019;20:247-260. https://doi.org/10.1016/j.redox.2018.09.025
- Kantharidis P, Wang B, Carew RM, Lan HY. Diabetes complications: the microRNA perspective. Diabetes. 2011;60:1832-1837. https://doi.org/10.2337/db11-0082
- Feng B, Chen S, McArthur K, Wu Y, Sen S, Ding Q, Feldman RD, Chakrabarti S. miR-146a-mediated extracellular matrix protein production in chronic diabetes complications. Diabetes. 2011;60:2975-2984. https://doi.org/10.2337/db11-0478
- Bhatt K, Lanting LL, Jia Y, Yadav S, Reddy MA, Magilnick N, Boldin M, Natarajan R. Anti-inflammatory role of microRNA-146a in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol. 2016;27:2277-2288. https://doi.org/10.1681/ASN.2015010111
- Feng Y, Chen L, Luo Q, Wu M, Chen Y, Shi X. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des Devel Ther. 2018;12:171-177. https://doi.org/10.2147/DDDT.S157109
-
Lu J, Wu DM, Zheng YL, Hu B, Cheng W, Zhang ZF, Li MQ. Troxerutin counteracts domoic acid-induced memory deficits in mice by inhibiting CCAAT/enhancer binding protein
${\beta}$ -mediated inflammatory response and oxidative stress. J Immunol. 2013;190:3466-3479. https://doi.org/10.4049/jimmunol.1202862 - Geetha R, Radika MK, Priyadarshini E, Bhavani K, Anuradha CV. Troxerutin reverses fibrotic changes in the myocardium of high-fat high-fructose diet-fed mice. Mol Cell Biochem. 2015;407:263-279. https://doi.org/10.1007/s11010-015-2474-3
- Zhang S, Li H, Zhang L, Li J, Wang R, Wang M. Effects of troxerutin on cognitive deficits and glutamate cysteine ligase subunits in the hippocampus of streptozotocin-induced type 1 diabetes mellitus rats. Brain Res. 2017;1657:355-360. https://doi.org/10.1016/j.brainres.2016.12.009
- Shu L, Zhang W, Huang G, Huang C, Zhu X, Su G, Xu J. Troxerutin attenuates myocardial cell apoptosis following myocardial ischemiareperfusion injury through inhibition of miR-146a-5p expression. J Cell Physiol. 2019;234:9274-9282. https://doi.org/10.1002/jcp.27607
- Zabihi NA, Mousavi SM, Mahmoudabady M, Soukhtanloo M, Sohrabi F, Niazmand S. Teucrium polium L. improves blood glucose and lipids and ameliorates oxidative stress in heart and aorta of diabetic rats. Int J Prev Med. 2018;9:110. https://doi.org/10.4103/ijpvm.ijpvm_189_17
- Najafi M, Farajnia S, Mohammadi M, Badalzadeh R, Ahmadi Asl N, Baradaran B, Amani M. Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts. J Diabetes Metab Disord. 2014;13:106. https://doi.org/10.1186/s40200-014-0106-1
- Sampath S, Karundevi B. Effect of troxerutin on insulin signaling molecules in the gastrocnemius muscle of high fat and sucrose-induced type-2 diabetic adult male rat. Mol Cell Biochem. 2014;395:11-27. https://doi.org/10.1007/s11010-014-2107-2
- Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond). 2005;109:143-159. https://doi.org/10.1042/CS20050025
- Lam TY, Seto SW, Lau YM, Au LS, Kwan YW, Ngai SM, Tsui KW. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic +db/+db mice. Eur J Pharmacol. 2006;546:134-141. https://doi.org/10.1016/j.ejphar.2006.07.003
- Mohammad A, Ali N, Reza B, Ali K. Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead. Indian J Pharmacol. 2010;42:78-81. https://doi.org/10.4103/0253-7613.64501
- Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res. 2007;55:498-510. https://doi.org/10.1016/j.phrs.2007.04.016
- Bullon P, Newman HN, Battino M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: a shared pathology via oxidative stress and mitochondrial dysfunction? Periodontol 2000. 2014;64:139-153. https://doi.org/10.1111/j.1600-0757.2012.00455.x
- Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, Wisse BE, Kirk EA, Chait A, Schwartz MW. Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28:1982-1988. https://doi.org/10.1161/ATVBAHA.108.169722
- Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res. 2004;63:582-592. https://doi.org/10.1016/j.cardiores.2004.05.001
- Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57:3090-3098. https://doi.org/10.2337/db08-0564
- Patel S, Santani D. Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep. 2009;61:595-603. https://doi.org/10.1016/s1734-1140(09)70111-2
-
Yu Y, Zheng G. Troxerutin protects against diabetic cardiomyopathy through
$NF-{\kappa}B$ /AKT/IRS1 in a rat model of type 2 diabetes. Mol Med Rep. 2017;15:3473-3478. https://doi.org/10.3892/mmr.2017.6456 - Zhang H, Liu J, Qu D, Wang L, Luo JY, Lau CW, Liu P, Gao Z, Tipoe GL, Lee HK, Ng CF, Ma RC, Yao X, Huang Y. Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2. Diabetes. 2016;65:1196-1207. https://doi.org/10.2337/db15-1067
- Yang M, Ye L, Wang B, Gao J, Liu R, Hong J, Wang W, Gu W, Ning G. Decreased miR-146 expression in peripheral blood mononuclear cells is correlated with ongoing islet autoimmunity in type 1 diabetes patients. J Diabetes. 2015;7:158-165. https://doi.org/10.1111/1753-0407.12163
- Garcia-Diaz DF, Pizarro C, Camacho-Guillen P, Codner E, Soto N, Perez-Bravo F. Expression of miR-155, miR-146a, and miR-326 in T1D patients from Chile: relationship with autoimmunity and inflammatory markers. Arch Endocrinol Metab. 2018;62:34-40. https://doi.org/10.20945/2359-3997000000006
- Feng B, Chen S, Gordon AD, Chakrabarti S. miR-146a mediates inflammatory changes and fibrosis in the heart in diabetes. J Mol Cell Cardiol. 2017;105:70-76. https://doi.org/10.1016/j.yjmcc.2017.03.002
-
Mann M, Mehta A, Zhao JL, Lee K, Marinov GK, Garcia-Flores Y, Lu LF, Rudensky AY, Baltimore D. An
$NF-{\kappa}B$ -microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun. 2017;8:851. https://doi.org/10.1038/s41467-017-00972-z -
Ye EA, Steinle JJ. miR-146a attenuates inflammatory pathways mediated by
$TLR4/NF-{\kappa}B$ and$TNF{\alpha}$ to protect primary human retinal microvascular endothelial cells grown in high glucose. Mediators Inflamm. 2016;2016:3958453. - Huang Y, Liu Y, Li L, Su B, Yang L, Fan W, Yin Q, Chen L, Cui T, Zhang J, Lu Y, Cheng J, Fu P, Liu F. Involvement of inflammationrelated miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol. 2014;15:142. https://doi.org/10.1186/1471-2369-15-142
Cited by
- Troxerutin attenuates inflammatory response in lipopolysaccharide-induced sepsis in mice vol.135, 2020, https://doi.org/10.1016/j.rvsc.2020.11.020
- Targeting inflammation, autophagy, and apoptosis by troxerutin attenuates methotrexate-induced renal injury in rats vol.103, 2020, https://doi.org/10.1016/j.intimp.2021.108284